COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People whose lung function test results show a specific pattern of reduced airflow (a ratio of two breathing measurements — FEV1 and FVC — that is less than 0.70), which can indicate a breathing condition such as COPD (confirm with trial site)
- People who are willing and able to understand and sign a written consent form agreeing to take part
Who may not be able to join:
- People with a history of asthma, bronchiectasis, a type of lung cancer called carcinoma of the bronchus, or any other significant lung or breathing condition
- People who are taking medications that suppress the immune system, or who currently have an active cancer diagnosis
- People who have been on steroid medication for a long period of time
- People who are under 40 years of age at the time of joining the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jadwiga Wedzicha, Imperial College London
Phone: 2075947947
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Annual exacerbation rate (number of exacerbations over a 12 month period)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.